| Literature DB >> 28115388 |
.
Abstract
The federal government has issued new guidance on the use of electronic tools to inform and obtain consent from potential participants in FDA-regulated research. The document answers common questions about how to present information to subjects and submit materials to regulators as part of new drug or device applications. ©2017 American Association for Cancer Research.Entities:
Mesh:
Year: 2017 PMID: 28115388 DOI: 10.1158/2159-8290.CD-NB2017-008
Source DB: PubMed Journal: Cancer Discov ISSN: 2159-8274 Impact factor: 39.397